Impact of pharmacist recommendations on the cost of drug therapy in ICU patients at a Malaysian hospital

被引:22
作者
Zaidi, STR
Hassan, Y
Postma, MJ
Ng, SH
机构
[1] King Abdul Aziz Hosp, Dept Pharmaceut Care, Natl Guards Hlth Afairs Eastern Reg, Al Hasa 31982, Saudi Arabia
[2] Univ Sains Malaysia, Sch Pharmaceut Sci, George Town, Malaysia
[3] Univ Groningen, GUIDE, GRIP, Groningen, Netherlands
[4] Ipoh Gen Hosp, Dept Anesthesia & Intens Care, Ipoh, Malaysia
来源
PHARMACY WORLD & SCIENCE | 2003年 / 25卷 / 06期
关键词
cost saving; drug-related problems; drug therapy; intensive care unit; interventions; Malaysia; pharmacist; pharmacist recommendations;
D O I
10.1023/B:PHAR.0000006524.52076.2f
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Objectives: To analyse clinical pharmacists interventions in the ICU of the Penang General Hospital (Penang, Malaysia) and to assess the pharmaco-economic impact of these interventions. Methods: A clinical pharmacist reviewed drug prescriptions during one month. Drug-related problems were documented on a preprepared form including a suggestion for a change in prescribing. Such recommendations were submitted to the nursing/medical staff. Acceptance of the recommendation was entirely at the discretion of the medical staff. All recommendations were analysed with respect to potential pharmaco-economic impact: cost savings, cost avoidance or cost addition. Results: The ICU pharmacist made 57 recommendations, of which the medical staff rejected only 5%. The majority of detected drug-related problems referred to unnecessary drug therapy (37%). Recommendations resulted in net cost savings of RM 15,227 (USD 4,007). This corresponded with RM 634 per patient intervened by the pharmacist. Conclusion: Pharmacists interventions in the ICU of a Malaysian hospital resulted in significant cost savings in terms of drug expenses and can therefore be suggested as a routine practice in our hospital.
引用
收藏
页码:299 / 302
页数:4
相关论文
共 11 条
[1]  
Chuang L C, 1994, Hosp Pharm, V29, P215
[2]  
CHUANG LC, 1994, HOSP PHARM, V29, P221
[3]   COMPREHENSIVE PHARMACEUTICAL SERVICES IN A MEDICAL INTENSIVE-CARE UNIT [J].
ELLINOY, BR ;
CLARKE, JE ;
WAGERS, PW ;
SWINNEY, RS .
AMERICAN JOURNAL OF HOSPITAL PHARMACY, 1984, 41 (11) :2335-2342
[4]   AN ANALYSIS OF CLINICAL PHARMACIST INTERVENTIONS IN AN INTENSIVE-CARE UNIT [J].
HASSAN, Y ;
AZIZ, NA ;
AWANG, J ;
AMINULDIN, AG .
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 1992, 17 (06) :347-351
[5]   Pharmacist participation on physician rounds and adverse drug events in the intensive care unit [J].
Leape, LL ;
Cullen, DJ ;
Clapp, MD ;
Burdick, E ;
Demonaco, HJ ;
Erickson, JI ;
Bates, DW .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 282 (03) :267-270
[6]   EFFECT OF PHARMACIST INTERVENTIONS ON DRUG-THERAPY COSTS IN A SURGICAL INTENSIVE-CARE UNIT [J].
MIYAGAWA, CI ;
RIVERA, JO .
AMERICAN JOURNAL OF HOSPITAL PHARMACY, 1986, 43 (12) :3008-3013
[7]   IMPACT OF A CLINICAL PHARMACIST IN A MULTIDISCIPLINARY INTENSIVE-CARE UNIT [J].
MONTAZERI, M ;
COOK, DJ .
CRITICAL CARE MEDICINE, 1994, 22 (06) :1044-1048
[8]   Effectiveness of a vancomycin restriction policy in changing the prescribing patterns of house staff [J].
Richardson, LP ;
Wiseman, SW ;
Malani, PN ;
Lyons, MJ ;
Kauffman, CA .
MICROBIAL DRUG RESISTANCE, 2000, 6 (04) :327-330
[9]  
Rudis MI, 2000, PHARMACOTHERAPY, V20, P1400
[10]  
Tschida SJ, 1996, PHARMACOTHERAPY, V16, P899